TY - JOUR
T1 - Neuroligin-mediated neurodevelopmental defects are induced by mitochondrial dysfunction and prevented by lutein in C. elegans
AU - Maglioni, Silvia
AU - Schiavi, Alfonso
AU - Melcher, Marlen
AU - Brinkmann, Vanessa
AU - Luo, Zhongrui
AU - Laromaine, Anna
AU - Raimundo, Nuno
AU - Meyer, Joel N.
AU - Distelmaier, Felix
AU - Ventura, Natascia
N1 - Funding Information:
We would like to thank Professor Tom Johnson at the University of Colorado Boulder and Professor Shane Rea (now at University of Washington) for making possible theinitial customized HMAD RNAi screening. We also would like to thank Alison Kell, Jenny Cho, and Alessandro Torgovnick for technical help with RNAi screen and lifespan; Professor Proksch at the Heinrich Heine University of Duesseldorf for the compound library used in the suppressor screen; Núria Benseny-Cases at MIRAS beamline in ALBA Synchrotron Light Source, Cerdanyola del Vallès in Barcelona, and Genis Rabost for technical assistance with FTIR measurements and analysis; Anthony Luz and Ian Ryde at Duke University for assistance with Seahorse XFe24 analysis and DNA damage assays respectively; Dirk Schwitters for qPCR on brains from WT and NDUFS4−/−mice. Finally, we thank the Caenorhabditis Genetics Center (funded by the National Institutes of Health Office of Research Infrastructure Programs: P40OD010440) as well as the National Bioresource Project (NBRP) for C. elegans strains and Professors Sieburth, Kaplan and Calahorro for providing additional mutants used in this work. The Wood-Whelan fellowship covered Silvia Maglioni costs to visit Joel Meyer Laboratory. This work was possible thanks to financial support from the German Research Foundation (DFG grants VE663-3/1 and VE663/8-1), the Federal Ministry of Education and Research (JPI-HDHL, Grant no. 01EA1602), and the Heinrich Heine University of Duesseldorf (Strategic Research Funding 2014) to NV; the National Institutes of Health (P42ES010356) to J.N.M., a fellowship from the China Scholarship Council (CSC201607030005) to Z.L.; the Spanish Ministry of Science, Innovation and Universities (RTI2018-096273-B-I00) and the ‘Severo Ochoa’ Programme for Centers of Excellence in R&D (SEV-2015-0496) to A.L.; the ERC Stg 337327 MitoPexLyso to N.R.
Funding Information:
We would like to thank Professor Tom Johnson at the University of Colorado Boulder and Professor Shane Rea (now at University of Washington) for making possible theinitial customized HMAD RNAi screening. We also would like to thank Alison Kell, Jenny Cho, and Alessandro Torgovnick for technical help with RNAi screen and lifespan; Professor Proksch at the Heinrich Heine University of Duesseldorf for the compound library used in the suppressor screen; Núria Benseny-Cases at MIRAS beamline in ALBA Synchrotron Light Source, Cerdanyola del Vallès in Barcelona, and Genis Rabost for technical assistance with FTIR measurements and analysis; Anthony Luz and Ian Ryde at Duke University for assistance with Seahorse XFe24 analysis and DNA damage assays respectively; Dirk Schwitters for qPCR on brains from WT and NDUFS4 mice. Finally, we thank the Caenorhabditis Genetics Center (funded by the National Institutes of Health Office of Research Infrastructure Programs: P40OD010440) as well as the National Bioresource Project (NBRP) for C. elegans strains and Professors Sieburth, Kaplan and Calahorro for providing additional mutants used in this work. The Wood-Whelan fellowship covered Silvia Maglioni costs to visit Joel Meyer Laboratory. This work was possible thanks to financial support from the German Research Foundation (DFG grants VE663-3/1 and VE663/8-1), the Federal Ministry of Education and Research (JPI-HDHL, Grant no. 01EA1602), and the Heinrich Heine University of Duesseldorf (Strategic Research Funding 2014) to NV; the National Institutes of Health (P42ES010356) to J.N.M., a fellowship from the China Scholarship Council (CSC201607030005) to Z.L.; the Spanish Ministry of Science, Innovation and Universities (RTI2018-096273-B-I00) and the ‘Severo Ochoa’ Programme for Centers of Excellence in R&D (SEV-2015-0496) to A.L.; the ERC Stg 337327 MitoPexLyso to N.R. −/−
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Complex-I-deficiency represents the most frequent pathogenetic cause of human mitochondriopathies. Therapeutic options for these neurodevelopmental life-threating disorders do not exist, partly due to the scarcity of appropriate model systems to study them. Caenorhabditis elegans is a genetically tractable model organism widely used to investigate neuronal pathologies. Here, we generate C. elegans models for mitochondriopathies and show that depletion of complex I subunits recapitulates biochemical, cellular and neurodevelopmental aspects of the human diseases. We exploit two models, nuo-5/NDUFS1- and lpd-5/NDUFS4-depleted animals, for a suppressor screening that identifies lutein for its ability to rescue animals’ neurodevelopmental deficits. We uncover overexpression of synaptic neuroligin as an evolutionarily conserved consequence of mitochondrial dysfunction, which we find to mediate an early cholinergic defect in C. elegans. We show lutein exerts its beneficial effects by restoring neuroligin expression independently from its antioxidant activity, thus pointing to a possible novel pathogenetic target for the human disease.
AB - Complex-I-deficiency represents the most frequent pathogenetic cause of human mitochondriopathies. Therapeutic options for these neurodevelopmental life-threating disorders do not exist, partly due to the scarcity of appropriate model systems to study them. Caenorhabditis elegans is a genetically tractable model organism widely used to investigate neuronal pathologies. Here, we generate C. elegans models for mitochondriopathies and show that depletion of complex I subunits recapitulates biochemical, cellular and neurodevelopmental aspects of the human diseases. We exploit two models, nuo-5/NDUFS1- and lpd-5/NDUFS4-depleted animals, for a suppressor screening that identifies lutein for its ability to rescue animals’ neurodevelopmental deficits. We uncover overexpression of synaptic neuroligin as an evolutionarily conserved consequence of mitochondrial dysfunction, which we find to mediate an early cholinergic defect in C. elegans. We show lutein exerts its beneficial effects by restoring neuroligin expression independently from its antioxidant activity, thus pointing to a possible novel pathogenetic target for the human disease.
UR - http://www.scopus.com/inward/record.url?scp=85130634361&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85130634361&partnerID=8YFLogxK
U2 - 10.1038/s41467-022-29972-4
DO - 10.1038/s41467-022-29972-4
M3 - Article
C2 - 35551180
AN - SCOPUS:85130634361
SN - 2041-1723
VL - 13
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 2620
ER -